T
TAK
Takeda Pharm
15.63
+0.21+1.36%After Hours: 15.63 0.00 0.00%16:10 06/18 EDT
OPEN/PREV CLOSE15.77/15.42
TODAY RANGE15.52-15.77
VOL2.44M
MARKET CAP49.39B
52 WEEK RANGE12.77-18.90
AVG VOL (3M)3.06M
% TURNOVER0.08%
TURNOVER--
P/E (TTM)-51.2795
% RANGE1.65%
EPS(TTM)-0.3048
P/E(FORWARD)49.65
P/B1.055
BVPS14.81
DIVIDEND0.6612
P/S1.740
BETA--
DIV YIELD4.23%
FREE FLOAT MKT CAP49.37B
SHARES OUTSTANDING3.16B
NEXT EARNINGS07/28-08/03
FREE FLOAT3.16B
LOT SIZE1
EX-DATE09/30/2025
News
Press Releases
Financial Reports
Profile
Benzinga·06/12 14:47
Silence Therapeutics Stock Rises On Positive Blood Cancer Drug Data
Seeking Alpha·06/11 19:27
Takeda Pharmaceutical: The Downside Was Forecastable
Benzinga·06/11 17:12
Takeda AI-Drug Shows Superior Skin Clearance Against Bristol-Myers' Med
Seeking Alpha·06/11 17:07
Takeda psoriasis drug tops Bristol-Myers Sotyktu in late-stage study
TipRanks·06/11 11:12
Takeda announces results for Phase 3 study of TAK-279
Seeking Alpha·06/10 12:04
Takeda gets FDA review for Entyvio label expansion in children
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.